Chris N. Barnes

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial”.

Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine(2025)10.1164/rccm.202410-1934oc

N/A

0.544DataRank · unranked

20 citations

Gregory P. Cosgrove, Scott Turner, Iris Y. Zhou, Nikos Efthimiou, Antonia Šušnjar +8 more

Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies

The Journal of Clinical Endocrinology & Metabolism(2021)10.1210/clinem/dgab438

N/A

0DataRank · unranked

41 citations

Chris N. Barnes, Michael Huang, Erik A. Imel, Ivy-Joan Madu, Deborah P. Merke +6 more